RBC Capital Markets has upgraded Cranswick PLC (LSE:CWK), the FTSE 250 premium food producer, to 'outperform' from 'sector perform', raising its price target to 6,100p from 5,500p and lifting earnings forecasts by 4% to 5% across its outlook.
Analyst Ross Broadfoot said a recent site visit and strong financial year 2026 delivery have reinforced his confidence that Cranswick's competitive advantages are durable and growing.
The central argument is that the company's vertically integrated model, spanning pig genetics through to retail packaging, gives it control over costs, quality and traceability that would take a new entrant at least a decade and more than £100 million a year to replicate.
RBC raised its adjusted operating profit forecasts primarily to reflect stronger margin guidance for the current financial year, with Cranswick targeting 7.9% for FY27, up from previous guidance of around 6%.
The broker is now 2% to 2.5% ahead of consensus across its forecast period, with adjusted operating profit estimated at £249 million for FY27, £265 million for FY28 and £281 million for FY29.
A key element of the bull case is poultry, where Cranswick will have added 43% new capacity by summer 2027.
If the new volumes prove fully incremental rather than partly replacing European imports, and if the group sustains the 8.2% operating margin achieved in the second half of FY26, RBC estimates that could drive a further 6% upgrade to FY29 group operating profit.
Beyond that, the proposed Eye 2 poultry facility, which would double capacity to 4 million birds per week and cost £175 million to £200 million, could add roughly £63 million to operating profit at full utilisation, a 22% uplift on base case forecasts.
Cranswick's two largest customers, Sainsbury's and Tesco, are both gaining share in the fresh and chilled market and growing their premium own-label ranges at around 15%, providing a supportive backdrop for the group's strategy of premiumisation.
The balance sheet offers further headroom, with net debt to adjusted EBITDA at just 0.2 times against available facilities of £450 million.
RBC values Cranswick on a discounted cash flow basis using a 7% weighted average cost of capital and a 3.5% terminal growth rate.